C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2011
10/27/2011	US20110263445 Multidentate Arrays
10/27/2011	US20110263442 Method of using biomarkers
10/27/2011	US20110263441 Compositions, kits, and methods for identification, assessment, prevention, and therapy of hepatic disorders
10/27/2011	US20110263440 Colorimetric bioassay for perchlorate
10/27/2011	US20110263439 Markers associated with alzheimer's disease
10/27/2011	US20110263438 Diagnosis and complication risk assessment of pancreatic diabetes using procalcitonin
10/27/2011	US20110263437 Analysis of Y-Chromosome STR Markers
10/27/2011	US20110263436 Recombinant antibodies against hepatitis c virus and methods of obtaining and using same
10/27/2011	US20110263435 Genetic markers for boar taint
10/27/2011	US20110263045 Method of Detection of Nucleic Acids With a Specific Sequence Composition
10/27/2011	US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011	US20110262972 Chondroitin Synthase, Method for Producing the Same and Method for Producing Saccharide Chain-Extended Chondroitin
10/27/2011	US20110262961 Diagnosis, Prevention and Treatment of Disorders Characterized by Undesirable Cell Proliferation
10/27/2011	US20110262960 Mycobacteria culture medium and method including mycobacteria of mycobacterium tuberculosis complex
10/27/2011	US20110262959 Method for evaluation of differentiation ability of stem cell
10/27/2011	US20110262958 Device for examining myocardial toxicity, chip for examining myocardial toxicity and method for examining myocardial toxicity
10/27/2011	US20110262957 Compositions for the detection of intracellular bacterial targets and other intracellular micororganism targets
10/27/2011	US20110262956 Co-culture compositions and methods
10/27/2011	US20110262955 Methods for determining sodium-proton-exchanger ligand efficiency
10/27/2011	US20110262954 Shuttle vector based transformation system for pyrococcus furiosus
10/27/2011	US20110262953 Phosphate Limited Inducible Promoter and A Bacillus Expression System
10/27/2011	US20110262952 Collection device and material
10/27/2011	US20110262951 Collection device and material
10/27/2011	US20110262950 Redox mediators
10/27/2011	US20110262949 Genetic incorporation of 3-aminotyrosine into reductases
10/27/2011	US20110262948 Methods of Quantifying Methotrexate Metabolites
10/27/2011	US20110262947 Isotopically-Labeled Proteome Standards
10/27/2011	US20110262946 Monitoring a dynamic system by liquid chromatography-mass spectrometry
10/27/2011	US20110262945 Glycoprotein production method and screening method
10/27/2011	US20110262944 Construction and crystallization of expression system for rna polymerase pb1-pb2 protein derived from influenza virus
10/27/2011	US20110262943 Reagent kit for measuring freshness
10/27/2011	US20110262942 Oxidizable species as an internal reference in control solutions for biosensors
10/27/2011	US20110262935 Method for detecting a prion infection
10/27/2011	US20110262930 Screening and Treatment Methods Using IGS5 Enzymes of the Metalloprotease Family
10/27/2011	US20110262929 Anti-hs6st2 antibodies and uses thereof
10/27/2011	US20110262928 Disease markers and uses thereof
10/27/2011	US20110262927 Analyzing bacteria without culturing
10/27/2011	US20110262926 Extracting low concentrations of bacteria from a sample
10/27/2011	US20110262925 Methods for isolating a target analyte from a heterogeneous sample
10/27/2011	US20110262924 Molecular assay for diagnosis of hiv tropism
10/27/2011	US20110262923 Method for the quantitative determination of the number of copies of a predetermined sequence in a sample
10/27/2011	US20110262922 Aptamer sandwich assays
10/27/2011	US20110262921 Test for the Detection of Bladder Cancer
10/27/2011	US20110262920 Methods for predicting survival in cancer patients
10/27/2011	US20110262919 Method for pretreating specimen and method for assaying biological substance
10/27/2011	US20110262918 Improved nanoparticulate compositions of poorly soluble compounds
10/27/2011	US20110262917 Modified nucleotides
10/27/2011	US20110262916 Non-invasive fetal rhd genotyping from maternal whole blood
10/27/2011	US20110262915 Method for predicting the athletic performance potential of a subject
10/27/2011	US20110262914 Methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseases
10/27/2011	US20110262913 Marking
10/27/2011	US20110262912 Method for measuring dna methylation
10/27/2011	US20110262911 Correcting an assay image of an array of signals generated from a multiplexed hybridization-mediated assay
10/27/2011	US20110262910 Marker for colon cancer and method for detecting colon cancer
10/27/2011	US20110262909 Genetic Markers for Horned and Polled Cattle and Related Methods
10/27/2011	US20110262908 Isolation of protein factors that associate directly or indirectly with nucleic acids
10/27/2011	US20110262907 Procecure for preparing a processed virtual analysis image
10/27/2011	US20110262906 Microfluidic multiplexed cellular and molecular analysis device and method
10/27/2011	US20110262905 Kit for the optimisation of protein synthesis/secretion
10/27/2011	US20110262904 Fluorescent dyes,methods of synthesis and applications thereof
10/27/2011	US20110262903 Modified Proteins and Methods of Making and Using Same
10/27/2011	US20110262902 Cis-acting diversification activator and method for selective diversification of nucleic acids
10/27/2011	US20110262901 Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm
10/27/2011	US20110262900 Male Reproductive Health Panel and Uses Thereof
10/27/2011	US20110262899 Fluorescent labeling of transfer rna and study of protein synthesis
10/27/2011	US20110262898 Compositions, Methods, and Kits for Amplifying Nucleic Acids
10/27/2011	US20110262897 Imaging techniques using a tridentate ligand
10/27/2011	US20110262896 System and method for multi-analyte detection
10/27/2011	US20110262895 Methods for the diagnosis of varicella zoster virus infection
10/27/2011	US20110262894 Vaccine against infectious agents having an intracellular phase, composition for the treatment and prevention of hiv infections, antibodies and methods of diagnosis
10/27/2011	US20110262893 Separating target analytes using alternating magnetic fields
10/27/2011	US20110262892 Methods for detection or measurement of viruses
10/27/2011	US20110262584 Bile resistant bacillus composition
10/27/2011	US20110262570 Transcriptional Profiling and Biomarker-Based Methods for Identifying and Evaluating Agents for Antioxidant Efficacy in Cosmetic Skin Care Formulations
10/27/2011	US20110262517 Chirally pure isomers of itraconazole and inhibitors of lanosterol 14a-demethylase for use as angiogenesis inhibitors
10/27/2011	US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses
10/27/2011	US20110262480 Method for producing multiple modifications in the chromosome of gram-negative bacteria and salmonella strains which are deficient in c-di-GMP synthesis obtained by said method
10/27/2011	US20110262468 Method for Monitoring Vaccine Response Using Single Cell Network Profiling
10/27/2011	US20110262467 Novel Artificial Antigen Presenting Cells and Uses Therefor
10/27/2011	US20110262465 Prostate stem cells and uses thereof
10/27/2011	US20110262464 Compositions, Kits, and Methods for the Diagnosis, Prognosis, and Monitoring of Cancer Using GOLPH3
10/27/2011	US20110262463 Syngr4 for target genes of cancer therapy and diagnosis
10/27/2011	US20110262462 Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
10/27/2011	US20110262459 Neamine Compositions and Methods of Use Thereof
10/27/2011	US20110262453 Markers for Assessing the Susceptibility of Cancer to IGF-1R Treatment
10/27/2011	US20110262451 Modulators of isovaleryl-coenzyme a dehydrogenase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011	US20110262450 Modulators of monoglyceride lipase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011	US20110262441 Method for selective control of helper t cell function
10/27/2011	US20110262437 Use of erbb4 as a prognostic and therapeutic marker for melanoma
10/27/2011	US20110262436 Treatment method
10/27/2011	US20110262434 Methods to Expand the Eligible Patient Population for HER2-Directed Targeted Therapies
10/27/2011	US20110262428 Treating cancer by modulating rna helicases
10/27/2011	US20110262426 Methods and kits used in identifying glioblastoma
10/27/2011	US20110262397 Compounds, compositions, and methods for control of hepatitis c viral infections
10/27/2011	US20110262395 Sensory receptors for chronic fatigue and pain and uses thereof
10/27/2011	US20110262391 Ca9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma
10/27/2011	US20110262383 Naphthalimide Dosing by N-Acetyl Transferase Genotyping
10/27/2011	US20110262366 Compounds for targeting endothelial cells, compositions containing the same and methods for their use
10/27/2011	US20110262364 Fluorescent Particles Comprising Nanoscale ZnO Layer and Exhibiting Cell-Specific Toxicity
10/27/2011	US20110262361 effective new drug target for the treatment of tuberculosis

1 ... 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 ... 3003